61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Bio-Rad Laboratories Inc
Closed
Sector Healthcare
329.42 1.69
Overview
Share price change
24h
Min
326.79
Max
329.97
Income | 2.8B 653M |
|---|---|
Sales | 11M 650M |
EPS | 2.01 |
Profit margin | 100.534 |
Employees | 8,030 |
EBITDA | 2.8B 107M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +20.78 upside |
Next Earnings | 13 Feb 2025 |
|---|
Market Cap | 72M 9.8B |
|---|---|
Previous open | 327.73 |
Previous close | 329.42 |
News Sentiment
By Acuity
50%
50%
157 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Bio-Rad Laboratories Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Bio-Rad Laboratories Inc Forecast
Price Target
By TipRanks
20.78% upside
12 Months Forecast
Average 399.2 USD 20.78%
High 481 USD
Low 315 USD
Based on 5 Wall Street analysts offering 12 month price targets forBio-Rad Laboratories Inc - Dist in the last 3 months.
Sentiment
By Acuity
157 / 392 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
